The first cluster randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

L Natoli, J Ward, B Hengel, L M Causer, S Badman, A Tangey, S N Tabrizi, D Whiley, B Donovan, C Fairley

Research output: Contribution to conferencePoster

Abstract

Introduction In many settings, control of sexually transmissible infections (STIs) is compromised by lack of laboratory infrastructure, physical distance from laboratories and loss to follow up of patients. Point-of-care (POC) tests have the potential to provide timely diagnosis, treatment and partner notification, and in turn reduce infection rates. In April 2013, we will implement the first cluster randomised trial of chlamydia and gonorrhoea POC testing in remote Aboriginal communities where STIs are endemic.
Original languageEnglish
PagesA345
Number of pages1
DOIs
Publication statusPublished - 14 Jul 2013
Externally publishedYes
EventSTI & AIDS World Congress 2013 : Threatening past, promising future - Vienna, Austria
Duration: 14 Jul 201317 Jul 2013

Conference

ConferenceSTI & AIDS World Congress 2013
CountryAustria
CityVienna
Period14/07/1317/07/13

Keywords

  • Chlamydia
  • Gonorrhoea
  • Point-of-Care

Fingerprint Dive into the research topics of 'The first cluster randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay'. Together they form a unique fingerprint.

Cite this